*TIRF-REMS = Transmucosal Immediate Release Fentanyl - Risk Evaluation and Mitigation Strategy
^Patient, Provider, and Pharmacy is required to register with TIRF-REMS Access Program
(e.g. Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys)
FDA rethinking TIRF-REMS* after nationally renowned...
This site uses cookies to help personalize content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies and terms of service.